Utah Medical Products, Inc. reported a 1.6% increase in revenues and a 19.2% increase in net income for the first quarter of 2023 compared to the same period in 2022. Earnings per share increased by 20.2%. The company's balance sheet remained strong with increased cash and investments.
Revenues increased by 1.6% compared to Q1 2022.
Net income increased by 19.2% compared to Q1 2022.
Earnings per share increased by 20.2% compared to Q1 2022.
Cash and investments increased to $80.9 million.
Management believes that the 1Q 2023 operating performance provides a start that is consistent with achieving its financial objectives for the calendar year 2023, as previously provided in its 2022 SEC 10-K Report.
Analyze how earnings announcements historically affect stock price performance